Affiliations 

  • 1 Abu Bakar Suleiman, MBBS, FRACP, Department of Nephrology, General Hospital Kuala Lumpur, Malaysia
  • 2 Zaki Morad Mohd Zaher, MBBS, MRCP Department of Nephrology, General Hospital Kuala Lumpur, Malaysia
  • 3 Chan S. H. MBBS, Ph D. WHO Immunology Research Centre, University of Singapore, Singapore
  • 4 Hussein Awang, MBBS, FRACS. Department of Urology, General Hospital Kuala Lumpur, Malaysia
Med J Malaysia, 1984 Mar;39(1):56-8.
PMID: 6239969

Abstract

The MtC tests performed prospectively was correlated with graft survival in 73 living, related grafts. The MLC was expressed as the relative response (RR), and graft survival assessed at six months, one year and two years. The l-haplotype matched grafts with high RR had poorer graft survival at one and two years than those with low RR, but this difference was not statistically significant.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.